S&P 500   3,383.92 (+1.51%)
DOW   27,962.16 (+0.99%)
QQQ   272.20 (+2.64%)
AAPL   449.76 (+2.80%)
MSFT   208.91 (+2.72%)
FB   260.71 (+1.79%)
GOOGL   1,505.20 (+1.67%)
AMZN   3,155.67 (+2.43%)
NVDA   454.73 (+4.78%)
CGC   17.40 (+2.65%)
BABA   255.74 (+2.95%)
TSLA   1,527.24 (+11.12%)
GE   6.63 (-1.49%)
MU   48.33 (+1.19%)
AMD   82.24 (+6.97%)
T   30.20 (-0.26%)
F   7.11 (-1.66%)
ACB   9.92 (-1.00%)
GILD   68.86 (+1.12%)
NFLX   479.79 (+2.75%)
DIS   131.35 (+0.66%)
BAC   26.56 (-1.34%)
BA   173.96 (-3.43%)
S&P 500   3,383.92 (+1.51%)
DOW   27,962.16 (+0.99%)
QQQ   272.20 (+2.64%)
AAPL   449.76 (+2.80%)
MSFT   208.91 (+2.72%)
FB   260.71 (+1.79%)
GOOGL   1,505.20 (+1.67%)
AMZN   3,155.67 (+2.43%)
NVDA   454.73 (+4.78%)
CGC   17.40 (+2.65%)
BABA   255.74 (+2.95%)
TSLA   1,527.24 (+11.12%)
GE   6.63 (-1.49%)
MU   48.33 (+1.19%)
AMD   82.24 (+6.97%)
T   30.20 (-0.26%)
F   7.11 (-1.66%)
ACB   9.92 (-1.00%)
GILD   68.86 (+1.12%)
NFLX   479.79 (+2.75%)
DIS   131.35 (+0.66%)
BAC   26.56 (-1.34%)
BA   173.96 (-3.43%)
S&P 500   3,383.92 (+1.51%)
DOW   27,962.16 (+0.99%)
QQQ   272.20 (+2.64%)
AAPL   449.76 (+2.80%)
MSFT   208.91 (+2.72%)
FB   260.71 (+1.79%)
GOOGL   1,505.20 (+1.67%)
AMZN   3,155.67 (+2.43%)
NVDA   454.73 (+4.78%)
CGC   17.40 (+2.65%)
BABA   255.74 (+2.95%)
TSLA   1,527.24 (+11.12%)
GE   6.63 (-1.49%)
MU   48.33 (+1.19%)
AMD   82.24 (+6.97%)
T   30.20 (-0.26%)
F   7.11 (-1.66%)
ACB   9.92 (-1.00%)
GILD   68.86 (+1.12%)
NFLX   479.79 (+2.75%)
DIS   131.35 (+0.66%)
BAC   26.56 (-1.34%)
BA   173.96 (-3.43%)
S&P 500   3,383.92 (+1.51%)
DOW   27,962.16 (+0.99%)
QQQ   272.20 (+2.64%)
AAPL   449.76 (+2.80%)
MSFT   208.91 (+2.72%)
FB   260.71 (+1.79%)
GOOGL   1,505.20 (+1.67%)
AMZN   3,155.67 (+2.43%)
NVDA   454.73 (+4.78%)
CGC   17.40 (+2.65%)
BABA   255.74 (+2.95%)
TSLA   1,527.24 (+11.12%)
GE   6.63 (-1.49%)
MU   48.33 (+1.19%)
AMD   82.24 (+6.97%)
T   30.20 (-0.26%)
F   7.11 (-1.66%)
ACB   9.92 (-1.00%)
GILD   68.86 (+1.12%)
NFLX   479.79 (+2.75%)
DIS   131.35 (+0.66%)
BAC   26.56 (-1.34%)
BA   173.96 (-3.43%)
Log in

NYSE:DHRDanaher Stock Price, Forecast & News

$205.92
+5.91 (+2.95 %)
(As of 08/12/2020 01:57 PM ET)
Add
Compare
Today's Range
$201.37
Now: $205.92
$206.84
50-Day Range
$171.46
MA: $189.55
$206.83
52-Week Range
$119.60
Now: $205.92
$207.66
Volume56,567 shs
Average Volume3.17 million shs
Market Capitalization$146.08 billion
P/E Ratio44.09
Dividend Yield0.36%
Beta0.95
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments; Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and molecular diagnostics products. This segment offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides equipment, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia. Cepheid, a company which is developing a faster test for COVID-19, is a subsidiary of Danaher.
Read More
Danaher logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.5Community Rank: 3.1Dividend Strength: 1.7Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.77 out of 5 stars


Industry, Sector and Symbol

Industry Process control instruments
Sub-IndustryIndustrial Conglomerates
CUSIP23585110
Phone202-828-0850

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$17.91 billion
Cash Flow$6.23 per share
Book Value$39.93 per share

Profitability

Net Income$3.01 billion

Miscellaneous

Employees60,000
Market Cap$146.08 billion
Next Earnings Date10/22/2020 (Estimated)
OptionableOptionable
$205.92
+5.91 (+2.95 %)
(As of 08/12/2020 01:57 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive DHR News and Ratings via Email

Sign-up to receive the latest news and ratings for DHR and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Danaher (NYSE:DHR) Frequently Asked Questions

How has Danaher's stock been impacted by COVID-19 (Coronavirus)?

Danaher's stock was trading at $139.37 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, DHR stock has increased by 47.8% and is now trading at $205.92.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of Danaher?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Danaher in the last year. There are currently 1 hold rating and 11 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Danaher
.

When is Danaher's next earnings date?

Danaher is scheduled to release its next quarterly earnings announcement on Thursday, October 22nd 2020.
View our earnings forecast for Danaher
.

How were Danaher's earnings last quarter?

Danaher Co. (NYSE:DHR) posted its quarterly earnings results on Thursday, July, 23rd. The conglomerate reported $1.44 EPS for the quarter, beating the consensus estimate of $1.09 by $0.35. The conglomerate earned $5.30 billion during the quarter, compared to analysts' expectations of $5.01 billion. Danaher had a net margin of 17.73% and a return on equity of 11.88%. The company's revenue for the quarter was up 2.7% compared to the same quarter last year. During the same period last year, the company posted $1.09 EPS.
View Danaher's earnings history
.

How often does Danaher pay dividends? What is the dividend yield for Danaher?

Danaher declared a quarterly dividend on Tuesday, May 5th. Stockholders of record on Friday, June 26th will be paid a dividend of $0.18 per share on Friday, July 31st. This represents a $0.72 annualized dividend and a dividend yield of 0.35%. The ex-dividend date is Thursday, June 25th.
View Danaher's dividend history
.

What price target have analysts set for DHR?

12 brokers have issued 12-month target prices for Danaher's shares. Their forecasts range from $169.00 to $233.00. On average, they expect Danaher's share price to reach $197.36 in the next twelve months. This suggests that the stock has a possible downside of 4.2%.
View analysts' price targets for Danaher
.

Has Danaher been receiving favorable news coverage?

Headlines about DHR stock have trended negative this week, according to InfoTrie Sentiment. InfoTrie identifies negative and positive press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Danaher earned a media sentiment score of -2.2 on InfoTrie's scale. They also gave press coverage about the conglomerate a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the next few days.
View the latest news about Danaher
.

Are investors shorting Danaher?

Danaher saw a decrease in short interest in February. As of February 15th, there was short interest totaling 6,520,000 shares, a decrease of 15.8% from the January 31st total of 7,740,000 shares. Based on an average trading volume of 10,690,000 shares, the days-to-cover ratio is presently 0.6 days. Approximately 1.1% of the shares of the company are short sold.
View Danaher's Short Interest
.

Who are some of Danaher's key competitors?

What other stocks do shareholders of Danaher own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Danaher investors own include NVIDIA (NVDA), Walt Disney (DIS), Home Depot (HD), Cisco Systems (CSCO), Johnson & Johnson (JNJ), Intel (INTC), AbbVie (ABBV), Adobe (ADBE), Alibaba Group (BABA) and Visa (V).

Who are Danaher's key executives?

Danaher's management team includes the following people:
  • Mr. Thomas P. Joyce Jr., CEO, Pres & Director (Age 59)
  • Mr. Daniel L. Comas, Exec. VP (Age 56)
  • Mr. William K. Daniel II, Exec. VP (Age 55)
  • Mr. Rainer M. Blair, Exec. VP (Age 56)
  • Mr. Joakim Weidemanis, Exec. VP (Age 50)

What is Danaher's stock symbol?

Danaher trades on the New York Stock Exchange (NYSE) under the ticker symbol "DHR."

Who are Danaher's major shareholders?

Danaher's stock is owned by a variety of institutional and retail investors. Top institutional investors include Sumitomo Mitsui Trust Holdings Inc. (0.42%), Swiss National Bank (0.40%), Fisher Asset Management LLC (0.39%), Bessemer Group Inc. (0.39%), California Public Employees Retirement System (0.36%) and Principal Financial Group Inc. (0.28%). Company insiders that own Danaher stock include Alan G Spoon, Angela S Lalor, Brian W Ellis, Daniel L Comas, Daniel Raskas, Donald J Ehrlich, John T Schwieters, Linda P Hefner, Matthew Mcgrew, Mitchell P Rales, Rainer Blair, Robert S Lutz, Thomas Patrick Joyce Jr, Walter G Lohr, William K Daniel and William King.
View institutional ownership trends for Danaher
.

Which institutional investors are selling Danaher stock?

DHR stock was sold by a variety of institutional investors in the last quarter, including Toronto Dominion Bank, Walter & Keenan Financial Consulting Co. MI ADV, Cortland Associates Inc. MO, Prudential PLC, Boston Trust Walden Corp, Prudential Financial Inc., DAVENPORT & Co LLC, and Van Den Berg Management I Inc.. Company insiders that have sold Danaher company stock in the last year include Angela S Lalor, Daniel L Comas, Daniel Raskas, Donald J Ehrlich, John T Schwieters, Linda P Hefner, Matthew Mcgrew, Rainer Blair, Robert S Lutz, Thomas Patrick Joyce Jr, Walter G Lohr, William K Daniel, and William King.
View insider buying and selling activity for Danaher
.

Which institutional investors are buying Danaher stock?

DHR stock was purchased by a variety of institutional investors in the last quarter, including Fisher Asset Management LLC, Viking Global Investors LP, Candriam Luxembourg S.C.A., Healthcare of Ontario Pension Plan Trust Fund, Alberta Investment Management Corp, SeaTown Holdings Pte. Ltd., PGGM Investments, and California Public Employees Retirement System.
View insider buying and selling activity for Danaher
.

How do I buy shares of Danaher?

Shares of DHR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Danaher's stock price today?

One share of DHR stock can currently be purchased for approximately $205.92.

How big of a company is Danaher?

Danaher has a market capitalization of $146.08 billion and generates $17.91 billion in revenue each year. The conglomerate earns $3.01 billion in net income (profit) each year or $4.42 on an earnings per share basis. Danaher employs 60,000 workers across the globe.

What is Danaher's official website?

The official website for Danaher is www.danaher.com.

How can I contact Danaher?

Danaher's mailing address is 2200 PENNSYLVANIA AVE. N.W SUITE 800W, WASHINGTON DC, 20037. The conglomerate can be reached via phone at 202-828-0850 or via email at [email protected]

This page was last updated on 8/12/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.